Delivery Order SPE2DB22D3011-SPE2DB24FQ3RM
Award Date
9/5/24
Potential Completion Date
9/26/24
Potential Value
$2.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a $1,251.00 Firm Fixed Price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4564542915 INBRIJA 42 MG INHALATION CAP 60S. The contract has an ultimate completion date of May 30, 2024. This order is placed under AmerisourceBergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. The IDC allows the DLA to...
This is a $1,294.24 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of INBRIJA 42 MG INHALATION CAP 60S. The contract has an ultimate completion date of July 21, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract is for the delivery of INBRIJA 42 MG INHALATION CAP 60S, a pharmaceutical product, with a potential value of $1,251.00 and a completion date of March 21, 2024. The contract does not have a set-aside designation....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of INBRIJA 42 MG INHALATION CAP 60S. The contract has a ceiling value of $1,294.24 and runs through April 17, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The firm fixed price delivery order, valued at $1,251.00, is for the supply of the pharmaceutical product INBRIJA 42 MG INHALATION CAP 60S. This award does not have a set-aside designation. The delivery order falls under Amerisourcebergen Drug Corp's larger indefinite delivery contract (IDC) with DLA,...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of 60 units of the medication INBRIJA 42 MG INHALATION CAP. The contract has a ceiling value of $1,294.24 and a performance period through July 3, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,876.50 fixed-price delivery order is for the supply of INBRIJA 42 MG INHALATION CAP 60S, a specialty pharmaceutical product. The contract has a period of performance through September 17, 2024 and is not set-aside. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to provide a wide...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 60 units of the medication INBRIJA 42 MG INHALATION CAP. The contract has a ceiling value of $1,941.36 and a performance period ending on July 24, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves as a...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at one thousand two hundred fifty-one dollars to Amerisourcebergen Drug Corporation for INBRIJA 42 MG inhalation capsules. Under this order, Amerisourcebergen will deliver sixty capsules to a location in Conshohocken, Pennsylvania by mid-October to support the Defense Logistics Agency's medical supply needs. As a top pharmaceutical supplier, Amerisourcebergen frequently receives such small dollar, short-term...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of INBRIJA 42 MG INHALATION CAP 60S medication. The $1,294.24 firm fixed price contract was awarded on December 19, 2024 by the Defense Logistics Agency (DLA), which is a component of the Department of Defense that specializes in supply chain management and the procurement of medical supplies. The contract has an ultimate completion date of January 13, 2025 and is not designated as...